Recombinant Anti-IL2 Antibody (V3S-0522-YC975) (CAT#: V3S-0522-YC975)

Send Inquiry
  • fig1
    Figure 1 Anti-IL2 Monoclonal Antibody (V3S-0522-YC975) in ELISA
  • fig1
    Figure 2 Anti-IL2 Monoclonal Antibody (V3S-0522-YC975) in WB
  • fig1
    Figure 3 Anti-IL2 Monoclonal Antibody (V3S-0522-YC975) in DB

Datasheet

MSDS

COA

Summary
Property
Applications
Protocols
Target

Summary

Description This product is a monoclonal antibody derived from Human (Homo sapiens), which can specifically recognize Interleukin 2. The antibody is expressed with mammalian cell transient expression system, serum-free and purified by affinity chromatography. The purity and integrity are tested via SDS-PAGE and SEC-HPLC analysis. Given an antigen, additional QC measures are also desired such as affinity testing and binding validation.
Specifically, the antibody is provided in multiple formats for in vivo and in vitro assays. The Invivo version features greater than 95% purity, ultra-low endotoxin levels (<1 EU/mg or 0.1 EU/mg), and is preservative, stabilizer, and carrier protein-free.
Clonality Monoclonal
Host Species Human
Target Species Human
Isotype IgG1, λ

Property

Expression Species HEK293F or CHO
Conjugation None
Purity >95%, determined by SDS-PAGE and/or SEC-HPLC
Endotoxin <1 EU/mg, determined by LAL method
Purification Protein A affinity purified
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4⁰C within a week. For longer storage, aliquot and store at -20⁰C.

Applications

Application WB; DB; ELISA; FC; FuncS
Application Notes The antibody is recommended for detection of IL2 by ELISA, FC, FuncS assays.

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Flow Cytometry Protocol

Target

Target IL2
Alternative Name IL-2; TCGF; lymphokine
Gene ID 3558
UniProt P60568
Research Area Cardiovascular
Related Disease Autoimmune diseases and graft-versus-host disease

Tested Data

ELISA

Figure 1 Anti-IL2 Monoclonal Antibody (V3S-0522-YC975) in ELISA

ELISA analysis of V3S-0522-YC975 was performed by coating with human IL2 protein (His tag). Then blocked with BSA and incubated with V3S-0522-YC975. The HRP-conjugated goat anti-IgG as a secondary antibody (1: 2000). Detection was performed using TMB substrate and stopped with sulfuric acid. The absorbances were read on a spectrophotometer at 450 nm.

Figure 1 Anti-IL2 Monoclonal Antibody (V3S-0522-YC975) in ELISA

WB

Figure 2 Anti-IL2 Monoclonal Antibody (V3S-0522-YC975) in WB

Western blot analysis of V3S-0522-YC975 was performed by loading human IL2 protein onto a 12% Tris-HCl polyacrylamide gel. Proteins were transferred to a CN membrane and blocked with 5% skim milk for at least one hour. Membranes were probed with V3S-0522-YC975 and HRP goat anti-IgG (H+L) as a secondary antibody (1: 3000). Chemiluminescent detection was performed.

Figure 2 Anti-IL2 Monoclonal Antibody (V3S-0522-YC975) in WB

DB

Figure 3 Anti-IL2 Monoclonal Antibody (V3S-0522-YC975) in DB

Dot Blot analysis of V3S-0522-YC975 was performed by coating with human IL2 protein (His tag).

V3S-0522-YC975 incubation concentration: 2 μg/mL.
HRP-conjugated goat anti-IgG (H+L) as a secondary antibody (1: 3000)
NC: Negative control, PC: Positive control

Figure 3 Anti-IL2 Monoclonal Antibody (V3S-0522-YC975) in DB

For research use only, not directly for clinical use.
banner banner
© 2024 Creative Biolabs. All Rights Reserved.
antibody
Online Inquiry